Company intelligence / Profile preview

Sanzyme Biologics

Hyderabad, Telangana, India

Ownership: Private
Development stage: Other

Overview

Sanzyme Biologics has pioneered the commercial manufacture of spore-forming probiotics, with strains like Bacillus coagulans SNZ1969® supported by safety and efficacy data, including FDA GRAS and Health Canada approvals for certain strains; products are in commercial use globally[1][2][6].

Therapeutic areas: OtherGastroenterology
Modalities: Live biotherapeutic product therapyEnzymeProbiotic (recognized as a functional ingredient, not traditional therapy)
Industry: Non-Drug Biotech

Partnerships

Partnerships with major pharmaceutical, nutrition, and supplement companies in over 30-40 countries (names not disclosed)[2][3][7]

Beyond the preview

Go deeper on Sanzyme Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanzyme Biologics.

Explore the full profile